Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness

Diabetologia

Volumn 42, Issue 11, 1999, Pages 1367-1374

  Fernandez Real J M ^a   Ricart, W ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Cytokine; Insulin resistance; Leptin; Obesity; Thrifty genotype; TNF ; TNF receptor; Type II diabetes mellitus

Indexed keywords

INSULIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ACUTE PHASE RESPONSE; AUTOIMMUNITY; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INFLAMMATION; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CYTOKINES; DIABETES MELLITUS; EVOLUTION; GENOTYPE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PHENOTYPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032735973     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051451     Document Type: Review

References (82)

1. 1. Eaton SB, Konner M (1985) Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 312: 283-289
2. 2. Eaton SB, Konner M, Shostak M (1988) Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 84: 739-749
3. 3. Wendorf M, Goldfine ID (1991) Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes 40: 161-165
4. 4. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248
5. 5. Grimble R (1992) Dietary manipulation of the inflammatory response. Proc Nutri Soc 51: 285-294
6. 6. Kauffman CA, Jones PG, Kluger MJ (1986) Fever and malnutrition endogenous pyrogen/interleukin-1 in malnourished patients. Am J Clin Nutr 44: 449-452
7. 7. Vaisman N, Schattner A, Hahn T (1989) Tumor necrosis factor production during starvation. Am J Med 87: 115
8. 8. Murray MJ, Murray AB (1980) Cachexia: a "last ditch" mechanism of host defence? J R Coll Physicians Lond 14: 197-199
9. 9. Grimble RF (1998) Nutritional modulation of cytokine biology. Nutrition 14: 634-640
10. 10. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
11. 11. Crook MA, Tutt P, Pickup JC (1993) Elevated serum sialic acid concentration in non-insulin-dependent diabetes and its relationship to blood pressure and retinopathy. Diabetes Care 16: 57-60
12. 12. Crook MA, Tutt P, Simpson H, Pickup JC (1993) Serum sialic acid and acute phase proteins in Type 1 and 2 diabetes. Clin Chim Acta 219: 131-138
13. 13. Campos SP, Baumann H (1992) Insulin is a prominent modulator of the cytokine-stimulated expression of acute-plasma protein genes. Mol Cell Biol 12: 1789-1797
14. 14. Fernádez Real JM, Grasa M, Casamitjana R, Pugeat M, Barret C, Ricart W (1999) Plasma total and glycosylated corticosteroid binding globulin (CBG) levels are associated with insulin secretion. J Clin Endocrinol Metab (in press)
15. 15. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74-80
16. 16. Nieman DC (1997) Immune response to heavy exertion. J Appl Physiol 82: 1385-1394
17. 17. Koffler M, Kisch ES (1996) Starvation diet and very-low-calorie diets may induce insulin resistance and overt diabetes. J Diabetes Complications 10: 109-112
18. 18. Holness MJ, Sugden MC (1999) Antecedent protein restriction exarcebates development of impaired insulin action after high-fat feeding. Am J Physiol 276:E85-E93
19. 19. Ravelli AC, van der Meulen JH, Michels RP et al. (1998) Glucose tolerance in adults after prenatal exposure to famine. Lancet 351: 173-177
20. 20. Tuominen JA, Ebeling P, Bourey R et al. (1996) Postmarathon paradox: insulin resistance in the face of glycogen depletion. Am J Physiol 270:E336-E343
21. 21. Pedersen BK, Nieman DC (1998) Exercise immunology: integration and regulation. Immunol Today 19: 204-206
22. 22. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR et al. (1998) Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 30: 671-678
23. 23. Fernández-Real JM, Ricart W, Casamitjana R (1997) Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity. Clin Endocrinol (Oxf) 47: 583-588
24. 24. Paolisso G, Rizzo MR, Mazziotti G et al. (1998) Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 275 (2 Pt 1):E294-E299
25. 25. Caswell M, Pike LA, Bull BS, Stuart J (1993) Effect of age on tests of the acute-phase response. Arch Pathol Lab Med 117: 906-910
26. 26. Fagiolo U, Cossarizza A, Scala E (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375-2378
27. 27. Fernández-Real JM, BrochM, Ricart W et al. (1998) Plasma Levels of the Soluble Fraction of Tumor Necrosis Factor Receptor 2 and Insulin Resistance. Diabetes 47: 1757-1762
28. 28. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91
29. 29. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. J Clin Invest 94: 1543-1549
30. 30. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668
31. 31. Hotamisligil GS, Spiegelman BM (1994) Tumor Necrosis Factor a: A Key Component of the Obesity-Diabetes Link. Diabetes 43: 1271-1278
32. 32. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of Tumor Necrosis Factor in Human Adipose Tisssue. Regulation by Obesity, Weight Loss, and Relationship to Lipoprotein Lipase. J Clin Invest 95: 2111-2119
33. 33. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased Adipose Tissue Expression of Tumor Necrosis Factor-α in Human Obesity and Insulin Resistance. J Clin Invest 95: 2409-2415
34. 34. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The Expression of TNFa by Human Muscle. Relationship to Insulin Resistance. J Clin Invest 97: 1111-1116
35. 35. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R (1996) Effect of an Engineered Human Anti-TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients with NIDDM. Diabetes 45: 881-885
36. 36. Ventre J, Doebber T, Wu M et al. (1997) Targeted disruption of the tumor necrosis factor-α gene. Metabolic consequences in obese and nonobese mice. Diabetes 46: 1526-1531
37. 37. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389: 610-614
38. 38. Fernández-Real JM, Gutierrez C, Ricart W et al. (1997) The TNF-α Nco I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes 46: 1468-1472
39. 39. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumour necrosis factor alfa promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199
40. 40. Herrmann SM, Ricard S, Nicaud V et al. (1998) Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 28: 59-66
41. 41. McGuire W, Hill VS, Allsopp EM, Greenwood BM, Kwaitkowski D (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511
42. 42. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211: 833-839
43. 43. Fernández-Real JM, Gutierrez C, Ricart W et al. (1997) A TNF-β gene Nco I polymorphism is not associated with hypertrygliceridemia or insulin resistance in lean and obese subjects. Biochem Biophys Res Commun 236: 829-832
44. 44. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM (1997) Differential regulation of the p80 Tumor Necrosis Factor Receptor in human obesity and insulin resistance. Diabetes 46: 451-455
45. 45. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13: 151-153
46. 46. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation and death. Cell 76: 959-962
47. 47. Nophar Y, Kemper O, Brakebusch C et al. (1990) Soluble forms of tumor necrosis factors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9: 3269-3278
48. 48. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323-329
49. 49. Fernández-Real JM, Gutierrez C, Broch M, Casamitjana R, Vendrell J, Ricart W (1999) The Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1. Diabetes Care 22: 868-870
50. 50. Fernández-Real JM, Molina A, Broch M et al. (1999) The TNF system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 48: 1108-1112
51. 51. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H (1993) Selective upregulation of the 75-kDa tumor necrosis (TNF) receptor and its mRNA by TNF and LL-1. J Immunol 150: 4346-4353
52. 52. Neel JV (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress". Am J Hum Genet 14: 353-362
53. 53. Reaven GM (1998) Hypothesis: muscle insulin resistance is the ("not-so") thrifty genotype. Diabetologia 41: 482-484
54. 54. Schreyer SA, Chua SC, LeBoeuf RC (1998) Obesity and diabetes in TNF-alfa receptor-deficient mice. J Clin Invest 102: 402-411
55. 55. Shapiro L, Scherer PE (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8: 335-338
56. 56. Grunfeld C, Zhao C, Fuller J et al. (1996) Endotoxin and Cytokines Induce Expression of Leptin, the ob Gene Product, in Hamsters. A Role for Leptin in the Anorexia of Infection. J Clin Invest 97: 2152-2157
57. 57. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100: 2777-2782
58. 58. Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA (1998) Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 246: 660-667
59. 59. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP (1997) Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82: 4080-4082
60. 60. Mantzoros CS, Moschos S, Avramopoulos I et al. (1997) Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82: 3408-3413
61. 61. Chaudhri G, Clark IA (1989) Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol 143: 1290-1294
62. 62. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM (1991) Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 88: 4946-4950
63. 63. Fernández-Real JM, Ricart W, Arroyo E et al. (1998) Serum ferritin as a component of the Insulin Resistance syndrome. Diabetes Care 21: 62-68
64. 64. Fernández-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W (1999) C282Y and H63D mutations of the hemochromatosis candidate gene in Type II diabetes. Diabetes Care 22: 525-526
65. 65. Clinton SK, Fleet JC, Loppnow H et al. (1991) Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am J Pathol 138: 1005-1014
66. 66. Barath P, Fishbein MC, Cao J, Berenson J, Heifant RH, Forrester JS (1989) Detection and localization of TNF in human atheroma. Am J Cardiol 21: 1241-1251
67. 67. Kaartinen M, Penttilä A, Kovanen P (1996) Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation 94: 2787-2792
68. 68. Brito BE, Romano EL, Grunfeld C (1995) Increase lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. Clin Exp Immunol 101: 357-361
69. 69. Henninger DD, Gerritsen ME, Granger DN (1997) Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ Res 81: 274-281
70. 70. Fleet JC, Clinton SK, Salomon RN, Loppnow H, Libby P (1992) Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. J Nutr 122: 294-305
71. 71. Schreyer SA, Peschon JJ, LeBoeuf RC (1996) Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271: 26174-26178
72. 72. Fernández-Real JM, Gutierrez C, Ricart W et al. (1999) Plasma levels of the soluble fraction of tumor necrosis factor-α receptors 1 and 2 are independent determinants of total and LDL-Cholesterol concentrations in healthy subjects. Atherosclerosis (in press)
73. 73. Saikku P, Leinonen M, Mattila K et al. (1988) Serologic evidence of an association of a novel Chlamydia, TWAR, with coronary artery disease and acute myocardial infarction. Lancet 331:983-986
74. 74. Patel P, Mendall MA, Carrington D et al. (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311: 711-714
75. 75. Miettinen H, Lebto S, Saikku P et al. (1996) Association of Chlamydia pneumonia and coronary heart disease events in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 17: 682-688
76. 76. Gupta S, Camm AJ (1997) Chlamydia pneumoniae and coronary heart disease. BMJ 314: 1778-1779
77. 77. Mehta JL, Saldeen TG, Rand K (1998) Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31: 1217-1225
78. 78. Kol A, Sukhova GK, Lichtman AH, Libby P (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 98: 300-307
79. 79. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126
80. 80. Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279: 1477-1482
81. 81. Lev-Ran A (1999) Thrifty genotype: how applicable is it to obesity and Type II diabetes? Diabetes Rev 7: 1-22
82. 82. Hill AVS (1999) Defence by diversity. Nature 398: 668-669